This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Global Blood Therapeutics Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Ted Love

Geschäftsführender

US$8.2m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts8.7%
Amtszeit als Geschäftsführer8.3yrs
Eigentum des Geschäftsführers1.4%
Durchschnittliche Amtszeit des Managements6.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.8yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Ted Love im Vergleich zu den Einnahmen von Global Blood Therapeutics verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2022n/an/a

-US$322m

Mar 31 2022n/an/a

-US$310m

Dec 31 2021US$8mUS$716k

-US$303m

Sep 30 2021n/an/a

-US$277m

Jun 30 2021n/an/a

-US$266m

Mar 31 2021n/an/a

-US$249m

Dec 31 2020US$18mUS$661k

-US$248m

Sep 30 2020n/an/a

-US$282m

Jun 30 2020n/an/a

-US$286m

Mar 31 2020n/an/a

-US$291m

Dec 31 2019US$10mUS$597k

-US$267m

Sep 30 2019n/an/a

-US$220m

Jun 30 2019n/an/a

-US$199m

Mar 31 2019n/an/a

-US$182m

Dec 31 2018US$10mUS$569k

-US$174m

Sep 30 2018n/an/a

-US$166m

Jun 30 2018n/an/a

-US$152m

Mar 31 2018n/an/a

-US$135m

Dec 31 2017US$8mUS$520k

-US$117m

Sep 30 2017n/an/a

-US$103m

Jun 30 2017n/an/a

-US$95m

Mar 31 2017n/an/a

-US$89m

Dec 31 2016US$1mUS$479k

-US$82m

Sep 30 2016n/an/a

-US$71m

Jun 30 2016n/an/a

-US$65m

Mar 31 2016n/an/a

-US$58m

Dec 31 2015US$2mUS$438k

-US$51m

Vergütung im Vergleich zum Markt: Ted's total compensation ($USD8.19M) is above average for companies of similar size in the UK market ($USD2.71M).

Entschädigung vs. Einkommen: Ted's compensation has been consistent with company performance over the past year.


Geschäftsführer

Ted Love (63 yo)

8.3yrs

Amtszeit

US$8,193,309

Vergütung

Dr. Ted W. Love, M.D., serves as Independent Director at Royalty Pharma plc since July 30, 2020. He serves as Director of Seagen Inc. (formerly known as Seattle Genetics, Inc.). since August 2020. He serve...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Ted Love
President8.3yrsUS$8.19m1.37%
$ 63.2m
Jeffrey Farrow
CFO & Principal Accounting Officer6.5yrsUS$2.76m0.040%
$ 1.8m
Jung Choi
Chief Business & Strategy Officer7.5yrsUS$2.73m0.37%
$ 17.2m
David Johnson
Chief Commercial Officer4.6yrsUS$2.75m0.084%
$ 3.9m
Kim Smith-Whitley
Executive VP and Head of Research & Development1.4yrsUS$2.98m0.0089%
$ 409.5k
David Phillips
Founder & Advisor11.8yrskeine Datenkeine Daten
Matthew Jacobson
Founder & Advisor11.8yrskeine Datenkeine Daten
Andrej Sali
Founder & Advisor11.8yrskeine Datenkeine Daten
Nazila Habibizad
Executive Vice President of Operations2.5yrskeine Daten0.062%
$ 2.9m
Stephanie Yao
Senior Director of Corporate Communications & Investor Relationsno datakeine Datenkeine Daten
Patricia Suvari
Chief Legal Officer & Secretary6yrsUS$5.93m0.064%
$ 3.0m
Steven Immergut
Senior VP & Head of Corporate Communications3.8yrskeine Datenkeine Daten

6.5yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrenes Management: 0IVZ's management team is seasoned and experienced (6.5 years average tenure).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Ted Love
President9.1yrsUS$8.19m1.37%
$ 63.2m
Mark Perry
Lead Independent Director7.5yrsUS$348.28k0.056%
$ 2.6m
Wendy Yarno
Independent Director4.8yrsUS$320.78k0.017%
$ 783.3k
Deval Patrick
Independent Director2.4yrsUS$313.28k0.013%
$ 618.8k
Glenn Pierce
Independent Director6.7yrsUS$318.28k0.039%
$ 1.8m
Philip Pizzo
Independent Director7.1yrsUS$310.78k0.013%
$ 623.9k
Scott W. Morrison
Independent Director6.8yrsUS$333.28k0.0098%
$ 454.8k
Dawn Svoronos
Independent Director3.8yrsUS$316.36k0.0080%
$ 368.3k
Willie Brown
Advisor & Director Emeritusless than a yearUS$308.28k0.058%
$ 2.7m
Alexis Thompson
Independent Director1.6yrsUS$735.61k0.0049%
$ 226.5k

5.8yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: 0IVZ's board of directors are considered experienced (5.8 years average tenure).